Table 1.
Epidemiological and clinical characteristics of 81 HD patients
| Age (years) | 59.8 ± 15.7 |
|---|---|
| Male |
52 (64.2) |
| Dialysis duration (months) |
66.2 ± 53.9 |
| Diabetes mellitus |
17 (21) |
| Hypertension |
57 (70.4) |
| History of CVD |
30 (37) |
| Smoking |
25 (30.9) |
| Statins |
29 (35.8) |
| Anti-hypertensives |
57 (70,4) |
| Anti-HPTH treatment |
46 (56.8) |
| ESA |
73 (90,1) |
| Intravenous iron |
73 (90,1) |
| BMI (kg/m2) |
24.6 ± 4.1 |
| SAP (mmHg) |
136.1 ± 18.9 |
| DAP (mmHg) |
83.6 ± 12.1 |
| PP (mmHg) |
52.9 ± 13.8 |
| MAP (mmHg) | 100.9 ± 13.4 |
Values are expressed as mean±SD or numbers (%) as appropriate.
CVD cardiovascular disease, DAP diastolic arterial pressure, ESA erythropoiesis stimulating agent, HPTH hyperparathyroidism, MAP mean arterial pressure, PP pulse pressure, SAP systolic arterial pressure.